| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6062484 | Journal of Allergy and Clinical Immunology | 2016 | 23 Pages |
Abstract
This study suggests that p53 might act as a new potential therapeutic target against BSM remodeling in asthmatic patients.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Thomas PhD, Benoit PhD, Annaig MD, PhD, Elise Maurat, Isabelle PhD, Matthieu MD, Olga PhD, Jennifer PhD, Valérie PhD, Hugues MD, PhD, Pierre-Olivier MD, PhD, Roger MD, PhD, Patrick MD, PhD,